Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-18 DAWES KAREN A Director Sale −122 $139.32 $17K 120,293
2020-05-18 DAWES KAREN A Director Sale −180 $140.62 $25K 120,113
2020-05-18 DAWES KAREN A Director Sale −77 $141.45 $11K 120,036
2020-05-18 DAWES KAREN A Director Sale −80 $142.45 $11K 119,956
2020-05-15 KURIYEL RALF Senior VP, R&D Sale −435 $140.69 $61K 26,089
2020-05-15 Snodgres Jon Chief Financial Officer Sale −660 $140.43 $93K 32,267
2020-05-13 DAWES KAREN A Director Grant or award +722 121,556
2020-05-13 DAWES KAREN A Director Grant or award · Stock Option (Right to Buy) +1,761 1,761
2020-05-13 DAWES KAREN A Director Grant or award +722 121,556
2020-05-13 DAWES KAREN A Director Grant or award · Stock Option (Right to Buy) +1,761 1,761
2020-05-13 RYAN THOMAS F JR Director Grant or award +527 2,450
2020-05-13 RYAN THOMAS F JR Director Grant or award · Stock Option (Right to Buy) +1,285 1,285
2020-05-13 BARTHELEMY NICOLAS Director Grant or award +527 3,564
2020-05-13 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,285 1,285
2020-05-13 MUIR GLENN P Director Grant or award +527 5,905
2020-05-13 MUIR GLENN P Director Grant or award · Stock Option (Right to Buy) +1,285 1,285
2020-05-13 Snodgres Jon Chief Financial Officer Exercise or conversion +3,170 $26.05 $83K 39,297
2020-05-13 Snodgres Jon Chief Financial Officer Exercise or conversion +9,024 $32.40 $292K 48,321
2020-05-13 Snodgres Jon Chief Financial Officer Sale −5,358 $126.77 $679K 42,963
2020-05-13 Snodgres Jon Chief Financial Officer Sale −2,865 $127.75 $366K 40,098

Page 35 of 42 · 832 trades